Type II: UTSA CITE NSF I-Corps Site Proposal
Type II: UTSA CITE NSF I-Corps Site Proposal
批准号:
1735874
负责人:
Teja Guda
金额:
$29.98万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-01 至 2022-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The University of Texas (UTSA) proposes to renew their NSF I-Corps Site with additional goals of developing novel Intellectual Property (IP) policies that promulgate faculty and student involvement in launching technology ventures from the lab and bringing industry partners to campus. NSF Innovation Corps (I-Corps) Sites are NSF-funded entities established at universities whose purpose is to nurture and support multiple, local teams to transition their technology concepts into the marketplace. Sites provide infrastructure, advice, resources, networking opportunities, training and modest funding to enable groups to transition their work into the marketplace or into becoming I-Corps Team applicants. I-Corps Sites also strengthen innovation locally and regionally and contribute to the National Innovation Network of mentors, researchers, entrepreneurs and investors.In addition to fulfilling the Site goals, UTSA is also studying and working with I-Corps teams to develop a deeper understanding of the educational constructs associated with identifying and nurturing nascent technology entrepreneurs. Together these suggest new paradigms for designing technology commercialization programs and their impact on university-industry innovation ecosystems. The SITE at UTSA has broader impacts that include the creation of a transformational and progressive entrepreneurial ecosystem within the university environment that is essential to foster, support, develop, and commercialize new technologies. Such an ecosystem will not only help to change academic mindsets and cultures, but also result in higher competitiveness in global markets, increased external funding via follow-up research dollars, an enhanced educational environment for students and faculty, increased marketability of UT graduates, and greater financial returns to the university and community via technology commercialization. In addition, as a minority serving institution with a focus on veterans, UTSA has been very successful in achieving diversity among their teams. With continued support and NSF I-Corps designation, the CITE will expand its network of partnerships through the I-Corps Nodes, the NIN, and the growing number of regional partners.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1108/ijebr-03-2018-0169
发表时间:
2019
期刊:
International Journal of Entrepreneurial Behavior & Research
影响因子:
5.5
作者:
[Zanella, Gianluca, Castro Solano, Dante B., Hallam, Cory R.A., Guda, Teja]
通讯作者:
Guda, Teja
Managing the gap between disruptive innovation and people's perceptions: the case of wearable devices
管理颠覆性创新与人们认知之间的差距:以可穿戴设备为例
DOI:
10.1504/ijtip.2020.109776
发表时间:
2020
期刊:
International Journal of Technology Intelligence and Planning
影响因子:
--
作者:
[Zanella, Gianluca, Guda, Teja]
通讯作者:
Guda, Teja
CAREER: Programming Vascularization by Design in Porous Composites
-
批准号:1847103
-
项目类别:Continuing Grant
-
资助金额:$53.07万
-
财政年份:2019
-
负责人:Teja Guda
-
依托单位:
I-Corps: Infrared camera based detection of subsurface veins
-
批准号:1725036
-
项目类别:Standard Grant
-
资助金额:$5.0万
-
财政年份:2017
-
负责人:Teja Guda
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
-
批准号:2026JJ81984
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨石平
-
依托单位:
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
-
批准号:2026JJ30126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨沙
-
依托单位:
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵子方
-
依托单位:
苏合颗粒治疗慢性萎缩性胃炎的临床(II期)评价关键技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蒋晓波
-
依托单位:
医工融合策略下的新型NIR-II有机探针用于中晚期肝癌精准诊断与协同治疗
-
批准号:2026JJ30093
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈国栋
-
依托单位:
用于肺纤维化实时动态监测的NIR-II稀土纳米探针研究
-
批准号:JCZRLH202600246
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
以数据与知识双驱动的NIR-II荧光成像智能分析新范式与基础算法
-
批准号:JCZRMS202600521
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
桥粒斑蛋白调控II型肺泡上皮细胞凋亡易感性而促进特发性肺纤维化形成的机制研究
-
批准号:2026JJ70015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭菲
-
依托单位:
草鱼免疫球蛋白与GCRV-II互作机制及高效疫苗创制
-
批准号:JCZRQNA202600094
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
光敏型钌(II)配合物与喜树碱协同给药抗肝癌活性及作用机制研究
-
批准号:2026JJ81924
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谷依盈
-
依托单位: